Cannara Biotech (OTCMKTS:CNBTF) Stock Falls 0.9% – Here’s Why

Cannara Biotech (OTCMKTS:CNBTF) shares were down 0.9% during trading on Thursday. The company traded as low as $1.4670 and last traded at $1.4670. Approximately 300 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 33,127 shares. The stock had previously closed at $1.48.

Cannara Biotech Trading Down 0.9%

The business has a 50-day moving average of $1.46 and a two-hundred day moving average of $1.34.

Cannara Biotech Inc is a Canadian cannabis company that cultivates, manufactures and distributes cannabis products for the adult-use and medical markets. The company operates from Quebec and focuses on producing indoor-grown cannabis in a controlled environment.

Cannara’s product portfolio includes dried flower, pre-rolls, vape products, concentrates and other cannabis formats. Its consumer brands include Tribal, Nugz and Orchid CBD, which are marketed through authorized provincial cannabis distribution systems and retailers.

The company’s operations are centered on its cultivation and processing facilities in Quebec, supporting sales primarily in Canadian markets where its products are authorized for distribution.